The CKD Enigma with Misleading Statistics and Myths about CKD, and Conflicting ESRD and Death Rates in the Literature: Results of a 2008 US Population-Based Cross-Sectional CKD Outcomes Analysis

REFERENCES

• Moyer VA. On behalf of the US Preventive Services Task Force. Screening for chronic kidney disease: US Preventive Services task force recommendation statement. Ann Intern Med. August 28, 2012. doi:10.7326/0003-4819-157-8-201210160-00533 [Epub ahead of print].
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl. 1):S1–S266.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009;53(3 Suppl. 3):S4–S16.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA. The natural history of chronic kidney disease revisited – a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Adv Perit Dial. 2009;25:85–88.
   PubMedGoogle Scholar
• Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663.
   PubMed Web of Science ®Google Scholar
• Menon V, Wang X, Sarnak MJ, . Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int. 2008;73:1310–1315.
   PubMed Web of Science ®Google Scholar
• US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010. Available at: http://www.usrds.org/2010/ADR_booklet_2010_lowres.pdf, http://www.usrds.org/2009/pdf/V2_02_INC_PREV_09.PDF. Accessed December 20, 2010.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors – United States, 1999–2004. MMWR Morb Mortal Wkly Rep. 2007;56:161–165.
   PubMedGoogle Scholar
• Onuigbo M, Onuigbo N. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011;171(22):2066.
   PubMedGoogle Scholar
• The Concord Coalition. Escalating Health Care Costs and the Federal Budget, April 2, 2009. Available at: http://www.concordcoalition.org/files/uploaded_for_nodes/docs/Iowa_Handout_final.pdf.Accessed September 12, 2011.
   Google Scholar
• The Henry J. Kaiser Family Foundation. Snapshots: Health Care Spending in the United States and Selected OECD Countries, April 2011. Available at: http://www.kff.org/insurance/snapshot/OECD042111.cfm.Accessed September 12, 2011.
   Google Scholar
• Centers for Medicare and Medicaid Services. National Health Expenditure Projections 2010–2020. Available at: http://www.cms.gov/NationalHealthExpendData/downloads/proj2010.pdf. Accessed September 21, 2011.
   Google Scholar
• Sikaneta T, Abdolell M, Taskapan H, . Variability in CKD stage in outpatients followed in two large renal clinics. Int Urol Nephrol. 2011. doi:10.1007/s11255-011-9934-9.
   Google Scholar
• Onuigbo MA, Onuigbo NT. Variability in CKD stage in outpatients followed in two large renal clinics: Implications for CKD trials and the status of current knowledge of patterns of CKD to ESRD progression. Int Urol Nephrol. 2012;44(5);1589–1590 [Epub 2011 Aug 30].
   PubMedGoogle Scholar
• Sikaneta T, Roscoe J, Fung J, . Variability in CKD stage in outpatients followed in two large renal clinics: Implications for CKD trials and the status of current knowledge of patterns of CKD to ESRD progression: response to Dr. Onuigbo. Int Urol Nephrol. 2012;44(5);1591–1592 [Epub 2011 Oct 14].
   Google Scholar
• Onuigbo MA. The validity of current CKD staging paradigms revisited and disputed: a 2-year snap shot of stage IV CKD patients in a Mayo Clinic laboratory database: a call for process reengineering in nephrology practice. J Am Soc Nephrol. 2011;22:686A (SA-PO2472) (Abstract).
   Google Scholar
• Okusa MD, Chertow GM, Portilla D; Acute Kidney Injury Advisory Group of the American Society of Nephrology. The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol. 2009;4(3):520–522 [Epub 2009 Feb 18].
   PubMedGoogle Scholar
• Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: A new unrecognized pattern of CKD progression to ESRD. Ren Fail. 2010;32(8):954–958.
   PubMed Web of Science ®Google Scholar
• Onuigbo MAC, Onuigbo N. Syndrome of rapid onset end-stage renal disease revisited – Observations from two chronic kidney disease populations in two continents. US Nephrology. 2010;5(2):81–85.
   Google Scholar
• Onuigbo MA, Onuigbo N. Chronic Kidney Disease and RAAS Blockade: A New View of Renoprotection. London: Lambert Academic Publishing GmbH 11 & Co. KG; 2011.
   Google Scholar
• Onuigbo MAC, Onuigbo NTC. The syndrome of rapid onset end-stage renal disease (SOROESRD) – a new Mayo Clinic dialysis services experience, January 2010–February 2011. In: Di Iorio B, Heidland A, Onuigbo M, Ronco C, eds. Hemodialysis: How, When and Why. New York: NOVA Publishers; 2012:443–485.
   Google Scholar
• The GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349:1857–1863.
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Choi AI, Bertenthal D, . Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–2765.
   PubMed Web of Science ®Google Scholar
• Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD. Outcomes of stage 3–5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract. 2008;109:c109–c118.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Takei T, Shirota S, . Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population. Intern Med. 2008;47:1859–1864.
   PubMed Web of Science ®Google Scholar
• Conway B, Webster A, Ramsay G, . Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant. 2009;24:1930–1937.
   PubMed Web of Science ®Google Scholar
• Onuigbo MAC. Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET – a call for more circumspection. QJM. 2009;102:155–167 [Epub ahead of print January 5 2009].
   PubMed Web of Science ®Google Scholar
• Onuigbo M. Renoprevention: a new concept for re-engineering nephrology care: an economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Ren Fail. 2013;35(1):23–28.
   Google Scholar
• Onuigbo MAC. CKD express © – a new IT-software proposed for a paradigm change in CKD care. Open Med Inform J. 2012;6:26–27.
   PubMedGoogle Scholar
• Bansal N, Hsu CY. Long-term outcomes of patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008;4:532–533.
   PubMedGoogle Scholar
• Tsalamandris C, Allen TJ, Gilbert RE, . Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes. 1994;43:649–655.
   PubMed Web of Science ®Google Scholar
• Onuigbo MA. Causes of renal failure in patients with type 2 diabetes mellitus. J Am Med Assoc. 2003;290:1855.
   Google Scholar